MOTIVY
DEAD

Serial Number

90322039

Owner

GW Research Limited

Attorney

Michael T. Olsen

Filing Date

Nov 16, 2020

Add to watchlist:

No watchlists yet
View on USPTO

MOTIVY Trademark

Serial Number: 90322039

MOTIVY is a trademark filed by GW Research Limited on November 16, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

GW Research Limited (77 trademarks)

Sovereign House,

Entity Type: 98

Trademark Details

Filing Date

November 16, 2020

Registration Date

Not Registered

Published for Opposition

April 19, 2022

Goods & Services

Pharmaceutical preparations and substances for the treatment of neurological conditions, disorders and diseases; pharmaceutical preparations and substances for the treatment of pain, neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, cancer and cancer symptoms, perioperative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, hypoxic-ischaemic encephalopathy, symptoms of neurogenic disorders, movement disorders, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, psychiatric illnesses, post-traumatic stress disorders, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, crohn's disease, alzheimer's disease, bone disorders, inflammatory disorders, sleep and sleep disorders and drug, alcohol and nicotine abuse; medicinal oils; medicinal infusions for treating pain, neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, cancer and cancer symptoms, perioperative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, hypoxic-ischaemic encephalopathy, symptoms of neurogenic disorders, movement disorders, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, psychiatric illnesses, post-traumatic stress disorders, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, crohn's disease, alzheimer's disease, bone disorders, inflammatory disorders, sleep and sleep disorders and drug, alcohol and nicotine abuse; pure extracts of medicinal plants for medical purposes; plant extracts for pharmaceutical purposes

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jan 16, 2024 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jan 15, 2024 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 24, 2023 EXRA
SOU EXTENSION 2 GRANTED
May 22, 2023 EX2G
SOU EXTENSION 2 FILED
May 22, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
May 22, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 22, 2022 EXRA
SOU EXTENSION 1 GRANTED
Nov 20, 2022 EX1G
SOU EXTENSION 1 FILED
Nov 20, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 20, 2022 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 14, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 19, 2022 NPUB
PUBLISHED FOR OPPOSITION
Apr 19, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 30, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 13, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 12, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 11, 2022 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Feb 11, 2022 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sep 19, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
Sep 19, 2021 GNSL
SUSPENSION LETTER WRITTEN
Sep 19, 2021 CNSL
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 15, 2021 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Sep 15, 2021 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 15, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 15, 2021 REAP
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 20, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 20, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 20, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 3, 2021 GNRN
NON-FINAL ACTION E-MAILED
May 3, 2021 GNRT
NON-FINAL ACTION WRITTEN
May 3, 2021 CNRT
ASSIGNED TO EXAMINER
Apr 26, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 15, 2021 NWOS
NEW APPLICATION ENTERED
Nov 19, 2020 NWAP